These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26084672)

  • 1. Perturbation of the normal immune system in patients with CLL.
    Forconi F; Moss P
    Blood; 2015 Jul; 126(5):573-81. PubMed ID: 26084672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
    Haseeb M; Anwar MA; Choi S
    Front Immunol; 2018; 9():2720. PubMed ID: 30542344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunodeficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape.
    Sampalo A; Brieva JA
    Leuk Lymphoma; 2002 Apr; 43(4):881-4. PubMed ID: 12153179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
    Asslaber D; Qi Y; Maeding N; Steiner M; Denk U; Höpner JP; Hartmann TN; Zaborsky N; Greil R; Egle A
    Blood; 2019 Nov; 134(20):1717-1729. PubMed ID: 31537531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
    Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
    Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.
    Arruga F; Gyau BB; Iannello A; Vitale N; Vaisitti T; Deaglio S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of T cell/B cell interaction by B-CLL cells.
    Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
    Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
    Le Dieu R; Gribben J
    Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunodeficiency of chronic lymphocytic leukaemia.
    Hamblin AD; Hamblin TJ
    Br Med Bull; 2008; 87():49-62. PubMed ID: 18755702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
    Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
    Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
    Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
    Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
    Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection and immunity in chronic lymphocytic leukemia.
    Tsiodras S; Samonis G; Keating MJ; Kontoyiannis DP
    Mayo Clin Proc; 2000 Oct; 75(10):1039-54. PubMed ID: 11040852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
    Hanna BS; Öztürk S; Seiffert M
    Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes.
    Tomita Y; Avila-Cariño J; Yamamoto K; Mellstedt H; Klein E
    Immunol Lett; 1998 Feb; 60(2-3):73-9. PubMed ID: 9580478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia].
    Stelmach P; Robak T
    Postepy Hig Med Dosw (Online); 2013 Jun; 67():560-8. PubMed ID: 23799400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.
    Sun C; Tian X; Lee YS; Gunti S; Lipsky A; Herman SE; Salem D; Stetler-Stevenson M; Yuan C; Kardava L; Moir S; Maric I; Valdez J; Soto S; Marti GE; Farooqui MZ; Notkins AL; Wiestner A; Aue G
    Blood; 2015 Nov; 126(19):2213-9. PubMed ID: 26337493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and expansion of T cell from untreated patients with CLL: source of cells for immune reconstitution?
    Husebekk A; Fellowes V; Read EJ; Williams J; Petrus MJ; Gress RE; Fowler DH
    Cytotherapy; 2000; 2(3):187-93. PubMed ID: 12042041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.